Found: 41
Select item for more details and to access through your institution.
Vaccination in oncology practice and predictors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 12, p. 3537, doi. 10.1007/s00432-022-04055-5
- By:
- Publication type:
- Article
Objective Response Rate is a Surrogate Marker for Long-Term Overall Survival in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors.
- Published in:
- Clinical Genitourinary Cancer, 2024, v. 22, n. 5, p. N.PAG, doi. 10.1016/j.clgc.2024.102163
- By:
- Publication type:
- Article
Five-Year Outcome and Safety in Patients Treated With Immune Checkpoint Blockade Therapies for Urothelial Carcinoma: Experience From Real-World Clinical Practice.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 3, p. 334, doi. 10.1016/j.clgc.2022.11.019
- By:
- Publication type:
- Article
Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 6, p. 633, doi. 10.1007/s11912-024-01524-7
- By:
- Publication type:
- Article
Prevalence, etiology and risk factors of anemia in patients with newly diagnosed cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-20056-3
- By:
- Publication type:
- Article
Tanı Sırasında Böbrek Metastazı Olan Yassı Hücreli Akciğer Kanseri: Olgu Sunumu.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
How Shall We Name the Chemotherapy Administration Before and After Metastasectomy? How About “M-Neoadjuvant” and “M-Adjuvant”?
- Published in:
- 2010
- By:
- Publication type:
- Letter
Nivolumab-induced immune-related neutropenia in a renal cell carcinoma patient.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1797, doi. 10.1177/10781552231186748
- By:
- Publication type:
- Article
Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle?
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, p. 450, doi. 10.1177/1078155220988753
- By:
- Publication type:
- Article
Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study).
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1583, doi. 10.1177/1078155219900908
- By:
- Publication type:
- Article
Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1289, doi. 10.1177/1078155220924084
- By:
- Publication type:
- Article
The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1110, doi. 10.1177/1078155219883004
- By:
- Publication type:
- Article
A systematic review: Role of systemic therapy on treatment and prevention of brain metastasis in renal cell carcinoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 972, doi. 10.1177/1078155220905648
- By:
- Publication type:
- Article
Re: Combination of radiotherapy and immunotherapy? Do timing and dose matter?
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2062, doi. 10.1177/1078155219858176
- By:
- Publication type:
- Article
Sorafenib in Radioactive Iodine Refractory Differentiated Thyroid Cancer: A Real-life Data with Long-term Experience.
- Published in:
- Journal of Ankara University Faculty of Medicine / Ankara Üniversitesi Tip Fakültesi Mecmuasi, 2022, v. 75, n. 1, p. 103, doi. 10.4274/atfm.galenos.2021.24572
- By:
- Publication type:
- Article
Küçük Hücreli Dışı Akciğer Kanserinde Adjuvan Tedavi.
- Published in:
- Journal of Ankara University Faculty of Medicine / Ankara Üniversitesi Tip Fakültesi Mecmuasi, 2018, v. 71, n. 3, p. 112, doi. 10.4274/atfm.66375
- By:
- Publication type:
- Article
Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 12, p. 1973, doi. 10.1007/s00228-022-03403-1
- By:
- Publication type:
- Article
Ağrılı Kemik Metastazlarında Onkolojik Yaklaşımlar.
- Published in:
- Nuclear Medicine Seminars, 2020, v. 6, n. 1, p. 11, doi. 10.4274/nts.galenos.2020.003
- By:
- Publication type:
- Article
Comparison of Bone Scintigraphy and Ga-68-PSMA PET/CT in the Detection of Bone Metastases of Prostate Carcinoma.
- Published in:
- Nuclear Medicine Seminars, 2019, v. 5, p. 10
- By:
- Publication type:
- Article
Lu-177 PSMA Tedavisi Uygulanan Kastrasyona Dirençli Metastatik Prostat Kanserli Hastalarda Serum PSA Yanıtının Prognostik Önemi.
- Published in:
- Nuclear Medicine Seminars, 2018, v. 4, p. 32
- By:
- Publication type:
- Article
A Case of Diffuse Infiltrative Hepatocellular Carcinoma with Marked Response to Sorafenib Treatment Evidenced by <sup>18</sup>F-FDG PET/MRI.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Unveiling the Role of Human Papillomavirus in Urogenital Carcinogenesis a Comprehensive Review.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 5, p. 667, doi. 10.3390/v16050667
- By:
- Publication type:
- Article
Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 7, p. 1455, doi. 10.1002/ijc.33708
- By:
- Publication type:
- Article
Retrospective analysis of patients with relapsed or refractory germ cell tumors treated with autologous hematopoietic stem cell transplantation.
- Published in:
- Gulhane Medical Journal, 2018, v. 60, n. 4, p. 130, doi. 10.26657/gulhane.00037
- By:
- Publication type:
- Article
Adjuvant Concurrent Chemoradiotherapy (CRT) plus Docetaxel-Cisplatin-Fluorouracil (DCF) versus CRT plus Fluorouracil-Folinic Acid (FUFA) in Stage III Gastric Cancer.
- Published in:
- Journal of Cancer Research & Therapeutics, 2024, v. 20, n. 3, p. 913, doi. 10.4103/jcrt.jcrt_1009_20
- By:
- Publication type:
- Article
Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium.
- Published in:
- Urologia Internationalis, 2023, v. 107, n. 6, p. 595, doi. 10.1159/000528994
- By:
- Publication type:
- Article
The effect of primary tumour resection on patients with synchronous metastatic colorectal cancer treated with cetuximab‐containing regimens.
- Published in:
- ANZ Journal of Surgery, 2023, v. 93, n. 4, p. 945, doi. 10.1111/ans.18117
- By:
- Publication type:
- Article
Clinicopathological Characteristics and Oncological Outcomes of Non-urothelial Bladder Carcinomas: A Multicenter Study.
- Published in:
- Üroonkoloji Bülteni, 2021, v. 20, n. 2, p. 96, doi. 10.4274/uob.galenos.2020.1378
- By:
- Publication type:
- Article
Changes in Metastatic Castration Sensitive Prostate Cancer.
- Published in:
- Üroonkoloji Bülteni, 2021, v. 20, n. 1, p. 1, doi. 10.4274/uob.galenos.2019.1407
- By:
- Publication type:
- Article
Efficacy of Chemotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer Patients - Do Homologous Recombination Deficiency Affect the Outcomes?
- Published in:
- Üroonkoloji Bülteni, 2020, v. 19, n. 4, p. 175, doi. 10.4274/uob.galenos.2020.1555
- By:
- Publication type:
- Article
Nuclear Medicine Applications in Diagnosis of Urological Tumors.
- Published in:
- Üroonkoloji Bülteni, 2019, v. 18, n. 2, p. 80, doi. 10.4274/uob.galenos.2018.1132
- By:
- Publication type:
- Article
Targeted Agents and Resistance Mechanism in Renal Cell Cancer.
- Published in:
- Üroonkoloji Bülteni, 2019, v. 18, n. 2, p. 73, doi. 10.4274/uob.galenos.2018.1090
- By:
- Publication type:
- Article
Positron Emission Tomography in Renal Cell Carcinoma.
- Published in:
- Üroonkoloji Bülteni, 2018, v. 17, n. 2, p. 68, doi. 10.4274/uob.946
- By:
- Publication type:
- Article
Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 Project.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 5, p. 747, doi. 10.1007/s11523-024-01089-2
- By:
- Publication type:
- Article
Prognostic role of pan‐immune‐inflammation value in patients with metastatic castration‐resistant prostate cancer treated with androgen receptor‐signaling inhibitors.
- Published in:
- Prostate, 2022, v. 82, n. 15, p. 1456, doi. 10.1002/pros.24419
- By:
- Publication type:
- Article
Visceral Metastasis Predicts Response to New Hormonal Agents in Metastatic Castration-Sensitive Prostate Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 596, doi. 10.1093/oncolo/oyad102
- By:
- Publication type:
- Article
Emerging Strategies in Adjuvant Immunotherapy: A Comparative Review of Bladder Cancer and Renal Cell Carcinoma Treatments.
- Published in:
- Clinical Medicine Insights: Oncology, 2024, p. 1, doi. 10.1177/11795549241257238
- By:
- Publication type:
- Article
Cancer‐associated thrombosis and drug–drug interactions of antithrombotic and antineoplastic agents.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 20, p. 3216, doi. 10.1002/cncr.34937
- By:
- Publication type:
- Article